Vanguard Group’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$718K Buy
2024
Q2
Sell
2024
Q1
$416K Buy
2023
Q4
$539K Buy
2023
Q3
$467K Buy
2023
Q2
$461K Buy
2014
Q4
Sell
2014
Q3
$271K Buy
2014
Q2
$335K Sell
2014
Q1
$436K Buy
2013
Q4
$297K Buy
2013
Q3
$323K Buy
2013
Q2
$322K Buy